Novartis Pharma GmbH

Where the EU money came from

Funding by EU programme. Amounts are Novartis Pharma GmbH's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• MEL-PLEXPartner

  Exploiting MELanoma disease comPLEXity to address European research training needs in translational cancer systems biology and cancer systems medicine

  Horizon 2020 · 2014–2018 · Project on CORDIS ↗
• TARGETAMDPartner

  Transposon-based, targeted ex vivo gene therapy to treat age-related macular degeneration (AMD)

  FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Universitaetsklinikum AachenGermany · 2 shared projects
• Centre National de la Recherche Scientifique CNRSFrance · 1 shared project
• Katholieke Universiteit LeuvenBelgium · 1 shared project
• The Hebrew University of JerusalemIsrael · 1 shared project
• University College Dublin, National University of Ireland, DublinIreland · 1 shared project
• Rheinisch-Westfaelische Technische Hochschule AachenGermany · 1 shared project
• Technische Universitaet DresdenGermany · 1 shared project
• University of StuttgartGermany · 1 shared project
• Universite de GeneveSwitzerland · 1 shared project
• Ruprecht-Karls-Universitaet HeidelbergGermany · 1 shared project
• Universite du LuxembourgLuxembourg · 1 shared project
• Max Delbrueck Centrum Fuer Molekulare Medizin In der Helmholtz-Gemeinschaft (Mdc)Germany · 1 shared project
• Royal College of Surgeons In IrelandIreland · 1 shared project
• Universidad de NavarraSpain · 1 shared project
• Bundesinstitut Fur Impfstoffe und Biomedizinische ArzneimittelGermany · 1 shared project
• Kraeftens BekaempelseDenmark · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• drug discovery
• gene therapy
• mathematical model
• melanoma
• ophthalmology
• simulation software